Genomix selects CompaqSan Diego 20 September 2001 Structural GenomiX inked a multi-million dollar agreement with Compaq to develop SGX's high performance structural informatics systems. SGX will purchase a complete Compaq technology solution including Compaq AlphaServer systems, ProLiant servers running Linux, StorageWorks and services. SGX's drug discovery efforts will be speeded up by increasing SGX's ability to run its high-throughput protein modeling, molecular dynamics and chemical docking programs on a genomic scale.
The technology and services provided by Compaq will
assist SGX and its partners in target identification and validation, lead
selection and screening, and optimization of compounds for binding and
selectivity, with the goal of improving drug efficacy as well as predicting
and avoiding toxicity and negative side effects. As part of the agreement,
Compaq will build and install a high performance computing system consisting
initially of 200 Tru64 UNIX-based AlphaServer DS10L systems, two AlphaServer
GS80 systems in a TruCluster, one AlphaServer ES40 system, and a 140-processor
Linux-based Compaq ProLiant server cluster. SGX will also receive system
upgrades, support services, and early access to new technologies, including
access to the Intel Itanium microprocessor architecture.
Structural GenomiX (SGX) is working in experimental and computational
structural biology, transforming genomic information into structural templates
for drug discovery. SGX technologies include advanced bioinformatics tools
for target selection and structure annotation, automation of molecular biology
and protein biochemistry, high-throughput crystallization, protein structure
prediction by comparative modeling and ab initio methods, synthetic and
computational chemistry, and rapid co-complex structure determination.
Ad Emmen |
 |